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Background
Productivity of recombinant therapeutics is a coordinated
effort of multiple pathways in the cell [1]. The protein pro-
cessing pathway in endoplasmic reticulum has been the
target of many cell engineering studies but with mixed
results [2]. We have observed the induction of UPR genes
in recombinant CHO cells (data not shown). In this work,
we attempt to increase their productivity further by indu-
cing ER stress using a known UPR inducer.
Materials and methods
Cell culture
Suspension CHO cells secreting anti rhesus IgG were
grown in a media containing 50% PF-CHO (Hyclone) and
50% CDCHO (Invitrogen) supplemented with 4 mM
L-Glutamine (Invitrogen), 0.10% Pluronic (Invitrogen),
600 μg/ml G418 (Sigma) and 250 nM Methotrexate
(Sigma) in a total culture volume of 20 ml. All cultures
were run in replicates in 125 ml Erlenmeyer flasks (Corn-
ing). Cells were treated with tunicamycin (Sigma) for
12 hours and were harvested for RNA isolation. Cell den-
sities and viabilities were determined by a hemocytometer
using the tryphan blue exclusion method.
Quantitative real time PCR
Primers were designed based on consensus sequences from
human, mouse and rat and checked against the CHO gen-
ome database wherever available. Total RNA was isolated
using Tri reagent (Sigma) and converted to cDNA using
the Reverse Transcription kit (Thermo). 100 ng of cDNA
was used for qPCR to quantify the mRNA levels of differ-
ent UPR genes with Actin as the house keeping genes fol-
lowing the ΔΔCT method.
Antibody quantification
Antibody titres were quantified using the protocol as
described earlier by Chusainow et.al.,[3] and their speci-
fic productivities (qP) were also calculated.
Results
Induction of different ER stress genes was observed at
peak productivities in these recombinant CHO cell lines
(data not shown). Therefore, we hypothesized that
increasing the ER stress to higher levels may have an
additive effect on IgG productivity in these cell lines.
Tunicamycin a known ER stress inducer was used to
induce ER stress in these cells. CHO cells were treated
with tunicamycin (2.5 mM) for 12 hours and harvested
for RNA isolation. qPCR was performed to quantitate
the expression levels of different ER stress genes. IgG
HC and LC mRNA were also quantified and their fold
changes were also calculated. IgG titers in the superna-
tant were quantified using ELISA.
The IgG titers and cumulative productivities in the
tunicamycin treated and control cells are presented in
Figures 1a and 1b. 12 hours post-treatment with tunica-
mycin, the IgG titers increased to 460 μg/ml. Productiv-
ity in treated cells was found to be 25 pg/cell/day,
corresponding to a 1.7 fold increase compared to con-
trol cells. Interestingly, both the IgG HC and LC mRNA
were not induced in treated cells (Figure 1c, d). To elu-
cidate the role of UPR pathway in the observed increase
in productivity, expression of many chaperones and
UPR genes was measured. In response to tunicamycin,
chaperones including GRP78 and GRP94 were induced
to a maximum of 17-fold (Figures 1e, f). Co-chaperone
ERDJ4, involved in the translocation of nascent proteins
inside ER and activation of ERAD pathway [4], was also
induced in response to tunicamycin treatment indicating
increase in ER load. Figure 1g and 1h show the mRNA
profiles of ERDJ4 and EDEM in control and treated
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cells. No significant difference in expression of UGGT1
mRNA was observed, suggesting that there may be neg-
ligible mis-folded proteins (Figure 1i) which can be
recycled for refolding while most of them are continu-
ously degraded by the ERAD machinery. Highly active
transcription factors of the UPR pathway viz., GADD34,
CHOP and XBP1s were also induced in response to
tunicamycin treatment. Figures 1j-1l show the mRNA
profiles of different UPR genes. GADD34 was induced
to 38-folds on treatment while CHOP mRNA induced
to about 30-folds. Spliced XBP1 mRNA was also
induced to a maximum of 5.5-folds in treated cells lead-
ing to increased expression of GRP78 mRNA.
Conclusion
Engineering cells towards high productivity by exploiting
their cellular pathways has been gaining importance
recently in biopharmaceutical industries. The unfolded
protein response (UPR) pathway has also been targeted
to develop a high producing clone. However, the results
from previous engineering studies on this pathway are
either cell line or product dependent.
In this study, with prior knowledge on the induction of
different UPR genes at peak productivities, we attempted
to increase productivity by increasing ER stress using a
known UPR inducer, tunicamycin. Tunicamycin induced
the expression of chaperones and key UPR transcription
factors including GADD34 and XBP1s mRNA.
Increase in the levels of GRP78 and GRP94 mRNA with
no change in the levels of the UGGT1 mRNA suggests
that the treated cells may possess a highly active folding
pathway. Increase in the productivities with no change in
the levels of IgG HC and LC mRNA support our hypoth-
esis of an increased folding capacity in treated cells.
Hence, we suggest that the UPR pathway can be modu-
lated to increase the productivity.
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